Treatment of steroid unresponsive relapse with plasma exchange in aggressive multiple sclerosis

Therapeutic Apheresis and Dialysis

Volumn 14, Issue 3, 2010, Pages 298-302

  Habek, Mario ^a   Barun, Barbara ^a   Puretić, Zvonimir ^b   Brinar, Vesna V ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b KBC Zagreb   (Croatia)

Author keywords

Aggressive; Multiple sclerosis; Plasma exchange; Relapse

Indexed keywords

ALEMTUZUMAB; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; GLUCOCORTICOID;

ADULT; ARTICLE; BLOOD FILTER; CASE REPORT; CONVALESCENCE; DISEASE COURSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MALE; MEDICAL DECISION MAKING; MULTIPLE SCLEROSIS; PATIENT MONITORING; PLASMAPHERESIS; PRIORITY JOURNAL; RELAPSE; SYMPTOM; TIME; TREATMENT OUTCOME; DOSE RESPONSE; MULTIMODALITY CANCER THERAPY; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROCEDURES; RECURRENT DISEASE; YOUNG ADULT;

ADULT; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; METHYLPREDNISOLONE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PLASMA EXCHANGE; RECURRENCE; TIME FACTORS; YOUNG ADULT;

EID: 77952898447     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00794.x     Document Type: Article

References (9)

1. Fagius J, Lundgren J, Oberg G. Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation. Mult Scler 2009 15 : 229 237.
2. Schilling S, Linker RA, König FB et al. Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses: clinical experience with 16 patients. Nervenarzt 2006 77 : 430 438.
3. Lucchinetti CF, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000 47 : 707 717.
4. Keegan M, König F, McClelland R et al. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 2005 366 : 579 582.
5. Weinshenker BG, O'Brien PC, Petterson TM et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999 46 : 878 886.
6. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 2002 58 : 143 146.
7. Ruprecht K, Klinker E, Dintelmann T, Rieckmann P, Gold R. Plasma exchange for severe optic neuritis: treatment of 10 patients. Neurology 2004 63 : 1081 1083.
8. Bennetto L, Totham A, Healy P, Massey E, Scolding N. Plasma exchange in episodes of severe inflammatory demyelination of the central nervous system. A report of six cases. J Neurol 2004 251 : 1515 1521.
9. Sellebjerg F, Barnes D, Filippini G et al. EFNS Task Force on Treatment of Multiple Sclerosis Relapses. EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses. Eur J Neurol 2005 12 : 939 946.